Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2012-03-13 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: DAX (40100), Landes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DOASSANS : revenue, balance sheet and financial ratios
PHARMACIE DOASSANS is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in DAX (40100),
this company of category PME
shows in 2015 a revenue of 1.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DOASSANS (SIREN 750239584)
Indicator
2023
2022
2021
2017
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
1 101 895 €
Net income
-95 672 €
26 247 €
-35 561 €
41 817 €
61 240 €
35 399 €
EBITDA
N/C
N/C
N/C
N/C
N/C
87 142 €
Net margin
N/C
N/C
N/C
N/C
N/C
3.2%
Revenue and income statement
In 2023, PHARMACIE DOASSANS records a net loss of 96 k€. This deficit will reduce equity on the balance sheet.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-95 672 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 50%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 24%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
49.558%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
23.879%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2021
2022
2023
Debt ratio
243.816
183.471
152.805
82.325
71.7
49.558
Financial autonomy
24.893
29.29
33.18
34.1
36.678
23.879
Repayment capacity
20.048
None
None
None
None
None
Cash flow / Revenue
3.726%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
49.562023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good-8 pts over 3 years
In 2023, the debt ratio of PHARMACIE DOASSANS (49.56) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
23.88%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average-11 pts over 3 years
In 2023, the financial autonomy of PHARMACIE DOASSANS (23.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 40.92. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
40.92
Liquidity indicators evolution PHARMACIE DOASSANS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2021
2022
2023
Liquidity ratio
80.06
75.332
62.977
31.84
32.216
40.92
Interest coverage
38.193
None
None
None
None
None
Sector positioning
Liquidity ratio
40.922023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Watch
In 2023, the liquidity ratio of PHARMACIE DOASSANS (40.92) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DOASSANS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2021
2022
2023
Operating WCR
93 595 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
22
0
0
0
0
0
Customer payment term (days)
19
665
567
0
0
0
Supplier payment term (days)
55
1865
1729
0
0
0
Positioning of PHARMACIE DOASSANS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DOASSANS with other companies in the same sector:
Frequently asked questions about PHARMACIE DOASSANS
What is the revenue of PHARMACIE DOASSANS ?
The revenue of PHARMACIE DOASSANS in 2015 is 1.1 M€.
Is PHARMACIE DOASSANS profitable?
PHARMACIE DOASSANS recorded a net loss in 2023.
Where is the headquarters of PHARMACIE DOASSANS ?
The headquarters of PHARMACIE DOASSANS is located in DAX (40100), in the department Landes.
Where to find the tax return of PHARMACIE DOASSANS ?
The tax return of PHARMACIE DOASSANS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DOASSANS operate?
PHARMACIE DOASSANS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart